메뉴 건너뛰기




Volumn 30, Issue 10, 2012, Pages 1023-1024

A cautionary tale: Dosing chemotherapy in infants with retinoblastoma

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

EID: 84859726156     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.4254     Document Type: Editorial
Times cited : (32)

References (25)
  • 1
    • 78149480585 scopus 로고    scopus 로고
    • Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators
    • Canturk S, Qaddoumi I, Khetan V, et al: Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol 94:1432-1436, 2010
    • (2010) Br J Ophthalmol , vol.94 , pp. 1432-1436
    • Canturk, S.1    Qaddoumi, I.2    Khetan, V.3
  • 2
    • 58349113391 scopus 로고    scopus 로고
    • Survival with retinoblastoma in the USA: 1975-2004
    • Broaddus E, Topham A, Singh AD: Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 93:24-27, 2009
    • (2009) Br J Ophthalmol , vol.93 , pp. 24-27
    • Broaddus, E.1    Topham, A.2    Singh, A.D.3
  • 3
    • 0028914175 scopus 로고
    • External beam radiotherapy for retinoblastoma: I. Whole eye technique
    • Hungerford JL, Toma NM, Plowman PN, et al: External beam radiotherapy for retinoblastoma: I. Whole eye technique. Br J Ophthalmol 79:109-111, 1995
    • (1995) Br J Ophthalmol , vol.79 , pp. 109-111
    • Hungerford, J.L.1    Toma, N.M.2    Plowman, P.N.3
  • 4
    • 58049202910 scopus 로고    scopus 로고
    • Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up
    • Marees T, Moll AC, Imhof SM, et al: Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 100:1771-1779, 2008
    • (2008) J Natl Cancer Inst , vol.100 , pp. 1771-1779
    • Marees, T.1    Moll, A.C.2    Imhof, S.M.3
  • 10
    • 24044446891 scopus 로고    scopus 로고
    • Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma
    • Wilson MW, Haik BG, Liu T, et al: Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol 140:397-406, 2005
    • (2005) Am J Ophthalmol , vol.140 , pp. 397-406
    • Wilson, M.W.1    Haik, B.G.2    Liu, T.3
  • 11
    • 84859702888 scopus 로고    scopus 로고
    • Carboplatin-associated ototoxicity in children with retinoblastoma
    • Qaddoumi I, Bass JK, Wu J, et al: Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol 30:1034-1041, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 1034-1041
    • Qaddoumi, I.1    Bass, J.K.2    Wu, J.3
  • 13
    • 37549037496 scopus 로고    scopus 로고
    • A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy
    • Lambert MP, Shields C, Meadows AT: A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 50:223-226, 2008
    • (2008) Pediatr Blood Cancer , vol.50 , pp. 223-226
    • Lambert, M.P.1    Shields, C.2    Meadows, A.T.3
  • 14
    • 63649130636 scopus 로고    scopus 로고
    • Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma
    • Jehanne M, Lumbroso-Le Rouic L, Savignoni A, et al: Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 52:637-643, 2009
    • (2009) Pediatr Blood Cancer , vol.52 , pp. 637-643
    • Jehanne, M.1    Lumbroso-Le Rouic, L.2    Savignoni, A.3
  • 15
    • 70649113052 scopus 로고    scopus 로고
    • Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    • Ross CJ, Katzov-Eckert H, Dubé MP, et al: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41:1345-1349, 2009
    • (2009) Nat Genet , vol.41 , pp. 1345-1349
    • Ross, C.J.1    Katzov-Eckert, H.2    Dubé, M.P.3
  • 17
    • 0028202750 scopus 로고
    • Normalization of glomerular filtration rate in children: Body surface area, body weight or extracellular fluid volume?
    • Peters AM, Gordon I, Sixt R: Normalization of glomerular filtration rate in children: Body surface area, body weight or extracellular fluid volume? J Nucl Med 35:438-444, 1994 (Pubitemid 24079972)
    • (1994) Journal of Nuclear Medicine , vol.35 , Issue.3 , pp. 438-444
    • Peters, A.M.1    Gordon, I.2    Sixt, R.3
  • 18
    • 0141857724 scopus 로고    scopus 로고
    • Developmental pharmacology-drug disposition, action, and therapy in infants and children
    • Kearns GL, Abdel-Rahman SM, Alander SW, et al: Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157- 1167, 2003
    • (2003) N Engl J Med , vol.349 , pp. 1157-1167
    • Kearns, G.L.1    Abdel-Rahman, S.M.2    Alander, S.W.3
  • 19
    • 79951999971 scopus 로고    scopus 로고
    • Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: A report from the Children's Oncology Group
    • Dreyer ZE, Dinndorf PA, Camitta B, et al: Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: A report from the Children's Oncology Group. J Clin Oncol 29:214-222, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 214-222
    • Dreyer, Z.E.1    Dinndorf, P.A.2    Camitta, B.3
  • 20
    • 79958034086 scopus 로고    scopus 로고
    • Retinoblastoma therapy delivers power of chemotherapy with surgical precision
    • Friedrich MJ: Retinoblastoma therapy delivers power of chemotherapy with surgical precision. JAMA 305:2276-2278, 2011
    • (2011) JAMA , vol.305 , pp. 2276-2278
    • Friedrich, M.J.1
  • 23
    • 77957329916 scopus 로고    scopus 로고
    • Secondary hematopoietic malignancies in survivors of childhood cancer: An analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry
    • Rihani R, Bazzeh F, Faqih N, et al: Secondary hematopoietic malignancies in survivors of childhood cancer: An analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry. Cancer 116:4385-4394, 2010
    • (2010) Cancer , vol.116 , pp. 4385-4394
    • Rihani, R.1    Bazzeh, F.2    Faqih, N.3
  • 24
    • 84861214968 scopus 로고    scopus 로고
    • Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma
    • epub ahead of print on August 8, 2011
    • Turaka K, Shields CL, Meadows AT, et al: Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer [epub ahead of print on August 8, 2011]
    • Pediatr Blood Cancer
    • Turaka, K.1    Shields, C.L.2    Meadows, A.T.3
  • 25
    • 81355133299 scopus 로고    scopus 로고
    • Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma
    • Kaliki S, Shields CL, Shah SU, et al: Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol 129:1422-1427, 2011
    • (2011) Arch Ophthalmol , vol.129 , pp. 1422-1427
    • Kaliki, S.1    Shields, C.L.2    Shah, S.U.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.